trial · primary record
Autologous Anti-CD83 CAR T-cells
Recurrent Acute Myeloid Leukemia
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 26 |
| Primary completion | 2028-04-01 |
| Primary endpoint | Incidence of dose-limiting toxicity (DLT) |
| Registry ID | NCT06871410 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:26.576Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06871410
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.